The special edition of Näringsliv “Time to Unite”, brings an article about ReproUnion and an interview with Marcel van Duin, PhD, Senior Director, Ferring Pharmaceuticals.
Read the article here.
ReproUnion receives EUR 6.7 million to establish an innovation platform in the fight against infertility
In June 2023 ReproUnion was awarded 6.7 million euros to promote innovation in research and treatment of infertility, by establishing an innovation platform with new opportunities to reduce the risk of involuntary childlessness and improve fertility treatment. “The...